Wielenbach, Germany

Claudia Kirr

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc.. Active years: 2014-2016.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Claudia Kirr: Innovator in Enzymatic Activity Inhibition

Introduction

Claudia Kirr is a notable inventor based in Wielenbach, Germany. She has made significant contributions to the field of enzymatic activity inhibition, holding 2 patents that showcase her innovative work. Her research focuses on the development of reagents and compositions that effectively inhibit peroxidase activity.

Latest Patents

One of her latest patents involves the inhibition of peroxidase enzymatic activity. This invention addresses the need for effective reagents that can block peroxidase activity using an acidic aqueous solution of a protein denaturing agent. Preferred agents for this process include detergents and chaotropic substances, which play a crucial role in the inhibition mechanism.

Career Highlights

Throughout her career, Claudia has worked with prominent companies in the biotechnology sector, including Roche Diagnostics Operations, Inc. and Roche Molecular Systems, Inc. Her experience in these organizations has allowed her to refine her expertise and contribute to significant advancements in her field.

Collaborations

Claudia has collaborated with esteemed colleagues such as Manfred Watzele and Bernd Buchberger. These partnerships have further enriched her research and development efforts, leading to innovative solutions in enzymatic activity inhibition.

Conclusion

Claudia Kirr's work in the field of enzymatic activity inhibition exemplifies her dedication to innovation and research. Her patents and collaborations highlight her significant contributions to biotechnology, making her a noteworthy figure in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…